{"id":"https://openalex.org/W2914794847","doi":"https://doi.org/10.1182/blood-2018-99-115562","title":"TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of Cancer","display_name":"TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of Cancer","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2914794847","doi":"https://doi.org/10.1182/blood-2018-99-115562","mag":"2914794847"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-115562","doi":"https://doi.org/10.1182/blood-2018-99-115562","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115562","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110531774","display_name":"Sophia Colombari Figueroa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36373038","display_name":"Cleveland Clinic Lerner College of Medicine","ror":"https://ror.org/02x4b0932","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750","https://openalex.org/I36373038"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sophia Colombari Figueroa","raw_affiliation_strings":["Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Heights, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Heights, OH","institution_ids":["https://openalex.org/I36373038","https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114429797","display_name":"Bhumika J. Patel","orcid":"https://orcid.org/0009-0008-4984-7751","observed_orcids":["https://orcid.org/0009-0008-4984-7751"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhumika J. Patel","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089637417","display_name":"Shimoli Vipul Barot","orcid":"https://orcid.org/0000-0002-5313-9992","observed_orcids":["https://orcid.org/0000-0002-5313-9992"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shimoli Vipul Barot","raw_affiliation_strings":["Internal Medicine, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059910743","display_name":"Teodora Kuzmanovic","orcid":"https://orcid.org/0000-0003-2194-293X","observed_orcids":["https://orcid.org/0000-0003-2194-293X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Teodora Kuzmanovic","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086233229","display_name":"Aziz Nazha","orcid":"https://orcid.org/0000-0002-6695-7994","observed_orcids":["https://orcid.org/0000-0002-6695-7994"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aziz Nazha","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027080346","display_name":"Eric D. Hsi","orcid":"https://orcid.org/0000-0001-8623-4067","observed_orcids":["https://orcid.org/0000-0001-8623-4067"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric D. Hsi","raw_affiliation_strings":["Department of Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066731616","display_name":"James R. Cook","orcid":"https://orcid.org/0000-0003-0456-8085","observed_orcids":["https://orcid.org/0000-0003-0456-8085"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James R. Cook","raw_affiliation_strings":["Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102826236","display_name":"Sudipto Mukherjee","orcid":"https://orcid.org/0000-0002-8325-2603","observed_orcids":["https://orcid.org/0000-0002-8325-2603","https://orcid.org/0009-0002-0717-6319"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudipto Mukherjee","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron T. Gerds","raw_affiliation_strings":["Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129467","display_name":"Matt E Kalaycio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Kalaycio","raw_affiliation_strings":["Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082944296","display_name":"Anjali S. Advani","orcid":"https://orcid.org/0000-0003-0015-5902","observed_orcids":["https://orcid.org/0000-0003-0015-5902"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjali S. Advani","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085974329","display_name":"Jaroslaw Pawel Maciejewski","orcid":"https://orcid.org/0000-0002-6837-4346","observed_orcids":["https://orcid.org/0000-0002-6837-4346"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaroslaw P. Maciejewski","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5016810759","display_name":"Hetty E. Carraway","orcid":"https://orcid.org/0000-0001-5241-3614","observed_orcids":["https://orcid.org/0000-0001-5241-3614"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hetty E. Carraway","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5059910743"],"corresponding_institution_ids":["https://openalex.org/I1316902750"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"2270","last_page":"2270"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11642","display_name":"Genomics and Rare Diseases","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.9739999771118164},{"id":"https://openalex.org/keywords/germline-predisposition","display_name":"germline predisposition","score":0.8809999823570251},{"id":"https://openalex.org/keywords/family-history-of-cancer","display_name":"family history of cancer","score":0.6169999837875366},{"id":"https://openalex.org/keywords/variant-allele-frequency","display_name":"variant allele frequency","score":0.9139999747276306},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7590000033378601},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9100000262260437},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9940000176429749},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.40799999237060547},{"id":"https://openalex.org/keywords/germline-testing","display_name":"germline genetic testing","score":0.44699999690055847},{"id":"https://openalex.org/keywords/chromosomal-abnormalities","display_name":"chromosomal abnormalities","score":0.5339999794960022},{"id":"https://openalex.org/keywords/runx1","display_name":"RUNX1","score":0.4519999921321869},{"id":"https://openalex.org/keywords/gata2","display_name":"GATA2","score":0.9390000104904175}],"concepts":[{"id":"https://openalex.org/C2781179581","wikidata":"https://www.wikidata.org/wiki/Q2857712","display_name":"Family history","level":2,"score":0.6379733681678772},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.628808856010437},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.5835874080657959},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5551227331161499},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5357443690299988},{"id":"https://openalex.org/C2776071976","wikidata":"https://www.wikidata.org/wiki/Q14912280","display_name":"CHEK2","level":5,"score":0.44314947724342346},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4310503900051117},{"id":"https://openalex.org/C67636389","wikidata":"https://www.wikidata.org/wiki/Q784237","display_name":"Genetic predisposition","level":3,"score":0.42728888988494873},{"id":"https://openalex.org/C13514818","wikidata":"https://www.wikidata.org/wiki/Q5552256","display_name":"Germline mutation","level":4,"score":0.3959267735481262},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38186317682266235},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.36391133069992065},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35528215765953064},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.299568235874176},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22175991535186768},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.15232890844345093},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.10214751958847046},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-115562","doi":"https://doi.org/10.1182/blood-2018-99-115562","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-115562","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2563488553","https://openalex.org/W4321172407","https://openalex.org/W4405041975","https://openalex.org/W4417018117","https://openalex.org/W2412207040","https://openalex.org/W2598233326","https://openalex.org/W2801977495","https://openalex.org/W2597059478","https://openalex.org/W4417021747","https://openalex.org/W2950905566"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Next":[2],"generation":[3],"sequencing":[4],"(NGS)":[5],"of":[6,20,26,41,65,68,75,86,103,111,122,145,159,173,176,244,251,284,303,337,345,360,388,396,414,426,449,464,503,510,518,540,550,573,584,597,615,643,682,693,704,715,739,759,775,788,799],"bone":[7],"marrow":[8],"or":[9,684,695,706,717,741,761,777,790,801],"peripheral":[10],"blood":[11],"is":[12,89,127,593,635],"increasingly":[13],"being":[14],"used":[15],"in":[16,38,84,99,142,253,282,400,478,484,657],"the":[17,39,66,100,109,120,143,157,285,315,338,379,394,397,430,490,561,568,581,616],"upfront":[18],"evaluation":[19,134,656],"patients":[21,49,64,141,155,177,196,208,341,356,486,517,575,618,658],"with":[22,71,108,156,209,231,325,329,334,342,350,362,385,434,500,528,659],"a":[23,112,129,170,199,365,372,410,418,424,440,447,456,462,469,479,594,636,644],"new":[24],"diagnosis":[25,158,318,382],"myeloid":[27],"neoplasm":[28],"(MN).":[29],"This":[30,630],"testing":[31,70],"identifies":[32],"salient":[33],"mutations":[34,88,211,281,399],"that":[35,182,197,405,591,600,634,648],"are":[36,225],"relevant":[37,92,480],"biology":[40],"MN.":[42,235],"Information":[43],"obtained":[44],"from":[45,166],"NGS":[46,69,146,165],"can":[47,96],"inform":[48],"and":[50,59,222,246,255,272,309,331,369,421,443,467,506,545,571,612,641,651],"their":[51],"family":[52,93,249,358,386],"members":[53],"about":[54],"potential":[55],"predisposition":[56,138,233],"to":[57,73,118,178,216,228,234,560,604],"current":[58,82,130],"future":[60,204,628,645],"cancer":[61,245,252,377,389],"diagnosis.":[62],"Informing":[63],"utility":[67],"regard":[72],"detection":[74,85],"GL":[76,123,137,186,232,606,617,655],"risk":[77,558],"as":[78,80,219,259,261,291],"well":[79,260],"its":[81],"use":[83,570],"somatic":[87,608],"important.":[90],"Additional":[91,280],"history":[94,107,243,250,344,359,387],"data":[95],"be":[97,229],"combined":[98],"clinical":[101],"context":[102],"patient's":[104],"personal":[105,242],"oncologic":[106],"presence":[110],"variant":[113,266,425,448,463],"allele":[114,267],"frequency":[115,268],"(VAF)":[116],">30%-50%":[117],"enhance":[119],"prediction":[121],"predisposition.":[124],"However,":[125],"there":[126,592],"not":[128,214,577],"consensus/guideline":[131],"for":[132,135,139,274,515,639,654],"further":[133,185,392,602],"possible":[136,582],"MN":[140,160,195,598],"era":[144],"results.":[147,587],"Methods:":[148],"At":[149],"our":[150,192,301,401],"institution,":[151],"we":[152,190],"identified":[153,404],"401":[154],"who":[161],"were":[162,295,307,311,493,513],"sequenced":[163],"by":[164,322],"2012-2017.":[167],"We":[168,236,391,403],"performed":[169],"retrospective":[171],"review":[172],"this":[174],"panel":[175],"identify":[179],"specific":[180,240],"characteristics":[181,395],"may":[183,576],"warrant":[184,601],"testing.":[187],"Among":[188,429],"these,":[189,489],"focused":[191],"study":[193,647],"on":[194,580,622,678,689,700,711,735,755,771,784,795],"harbored":[198],"TP53":[200,276,398,412,436,458],"mutation":[201,270,277,413],"(N=66),":[202],"although":[203],"work":[205,633],"will":[206,619,649],"include":[207],"other":[210,287,476],"including":[212,364,371],"but":[213],"limited":[215],"genes":[217,289],"such":[218,290],"RUNX1,":[220],"GATA2,":[221],"ETV6":[223],"which":[224,415,460,519],"also":[226,296],"known":[227,427,450,465],"associated":[230],"collected":[237],"demographic":[238],"information,":[239],"diagnosis,":[241],"corresponding":[247],"treatment,":[248],"first":[254,366],"second":[256,373],"degree":[257,367,374],"relatives":[258],"cytogenetic":[262],"abnormalities.":[263],"The":[264],"location,":[265],"(VAF),":[269],"type,":[271],"significance":[273,466],"each":[275,502],"was":[278,314,378,461,482],"annotated.":[279,298],"any":[283],"36":[286],"disease-relevant":[288],"ASXL1,":[292],"BCOR,":[293],"JAK2":[294,496],"fully":[297],"Results:":[299],"In":[300,508],"cohort":[302,589,631],"66":[304],"patients,":[305],"27":[306],"females":[308],"39":[310],"males.":[312],"AML/ALL":[313],"most":[316,380,491],"common":[317,381,492],"(32/66;":[319],"48.5%)":[320],"followed":[321],"31.8%":[323],"(21/66)":[324],"MDS,":[326],"13.6%":[327],"(9/66)":[328],"MPN,":[330],"6%":[332],"(4/66)":[333],"MPN/MDS.":[335],"Clinically,":[336],"19":[339],"(30%)":[340],"prior":[343],"cancer,":[346,361],"13":[347],"had":[348,357,409,417,423,439,446,455,468,523,533,538,548],"treatment":[349],"chemotherapy":[351],"and/or":[352],"radiation.":[353],"Forty-four":[354],"(67%)":[355],"41":[363,422],"relative":[368],"9":[370],"relative.":[375],"Breast":[376],"among":[383],"those":[384,527],"(12/44).":[390],"examined":[393],"cohort.":[402],"48/66":[406],"(72.7%)":[407],"cases":[408,433,599],"single":[411],"43":[416],"VAF":[419,441,470],">30%":[420,442],"significance.":[428,451],"18/66":[431],"(27.3%)":[432],"two":[435],"mutations,":[437],"7":[438],"all":[444,555],"18":[445],"Only":[452],"1":[453],"case":[454],"third":[457],"mutation,":[459],">30%.":[471],"Additionally,":[472],"at":[473],"least":[474],"one":[475],"co-mutation":[477],"gene":[481],"seen":[483],"44%":[485],"(29/66).":[487],"Of":[488,526],"DNMT3A":[494],"(n=9),":[495],"(n=5),":[497,499],"TET2":[498],"3":[501],"BCORL1,":[504],"IDH2":[505],"NOTCH1.":[507],"terms":[509],"cytogenetics,":[511,530,535],"samples":[512],"available":[514],"60":[516],"only":[520],"4":[521],"(6.7%)":[522],"normal":[524],"cytogenetics.":[525],"abnormal":[529],"49/56":[531],"(87.5%)":[532],"complex":[534],"38/56":[536],"(67.9%)":[537],"deletion":[539,549],"chromosome":[541,551],"5q":[542],"(del":[543,553],"(5q))":[544],"21/56":[546],"(37.5%)":[547],"17p":[552],"(17p13.1)),":[554],"conferring":[556],"adverse":[557],"according":[559],"2017":[562],"European":[563],"LeukemiaNet":[564],"recommendations.":[565],"Conclusion:":[566],"Despite":[567],"widespread":[569],"availability":[572],"NGS,":[574],"have":[578],"clarity":[579,621],"implications":[583],"these":[585,624],"test":[586],"Our":[588],"demonstrates":[590],"significant":[595],"number":[596],"annotation":[603],"determine":[605],"versus":[607],"contributions.":[609],"Further":[610],"identification":[611],"follow":[613],"up":[614],"offer":[620],"how":[623],"genetic":[625],"risks":[626],"predict":[627],"outcomes.":[629],"represents":[632],"stepping":[637],"stone":[638],"design":[640],"justification":[642],"prospective":[646],"propose":[650],"validate":[652],"criteria":[653],"hematological":[660],"neoplasms.":[661],"Disclosures":[662],"Nazha:":[663],"MEI:":[664],"Consultancy.":[665,675],"Gerds:Apexx":[666],"Oncology:":[667],"Consultancy;":[668,670,672,723,726,729,749,812],"Incyte:":[669],"Celgene:":[671,687,709,793],"CTI":[673],"Biopharma:":[674],"Sekeres:Opsona:":[676],"Membership":[677,688,699,710,734,754,770,783,794],"an":[679,690,701,712,736,756,772,785,796],"entity's":[680,691,702,713,737,757,773,786,797],"Board":[681,692,703,714,738,758,774,787,798],"Directors":[683,694,705,716,740,760,776,789,800],"advisory":[685,696,707,718,742,762,778,791,802],"committees;":[686,697,708,792],"Opsona:":[698],"committees.":[719],"Maciejewski:Ra":[720],"Pharmaceuticals,":[721,731,747,751],"Inc:":[722,748],"Apellis":[724,727],"Pharmaceuticals:":[725,728],"Alexion":[730,750],"Inc.:":[732,752],"Consultancy,":[733,753,814],"committees,":[743,763,779,803],"Speakers":[744,764,767,780,806,809,815],"Bureau;":[745,768,781,807,810],"Ra":[746],"Bureau.":[765,816],"Carraway:Novartis:":[766],"Balaxa:":[769],"Amgen:":[782],"Research":[804],"Funding,":[805],"Jazz:":[808],"FibroGen:":[811],"Agios:":[813]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2019-02-21T00:00:00"}